Tiziana Life Sciences is trading 6.28% down at $0.90, amid broader risk-off pressure and no clear company-specific announcement identified for September 2, 2026.
- The official investor page lists the August 24 presentation announcement as the latest update, with no newer release shown through September 2.
- Nasdaq futures were down 0.52%, while geopolitical tensions, higher oil prices, and rising bond yields pressured growth-oriented equities.
- The stock has fallen in each of the last three reported sessions.